Search - tctmd.com

Displaying 941 - 960 of 1484

Sort: Relevancy | Date

News Industry News

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

September 16, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Industry News

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

September 16, 2014

News Industry News

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

September 16, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Conference News TCT 2014

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

September 15, 2014

News Industry News

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Industry News

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

September 14, 2014

News Industry News

First of Its Kind Study Compares Outcomes of Fractional Flow Reserve-Guided and Angiography-Guided Provisional Side Branch Stenting

September 14, 2014

News Conference News TCT 2014

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

September 14, 2014

News Conference News TCT 2014

ABSORB EXTEND: BVS Safe Out to 3 Years

September 14, 2014

News Daily News

女性在直接PCI后的左心室功能更差的可能原因是就诊延迟

L.A. McKeown

September 13, 2014

News Daily News

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

L.A. McKeown

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Daily News

El Empeoramiento de la Función VI tras una PCI Primaria de las Mujeres podría Deberse a Retrasos a la Hora de Acudir al Hospital

L.A. McKeown

September 13, 2014

Advertisement

STENTYS Stent continues to show low mortality two years after treatment of a heart attack

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

InspireMD Announces Positive Results from CGuard™ CARENET Trial with 0% MACE reported at 30 Days

Amarin Reaffirms Its Mission to Improve Patient Care With Commitment to Completing REDUCE-IT Cardiovascular Outcomes Study

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

OPTIMIZE: Short-term DAPT Safe 2 Years After ZES Implantation

Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

COMBO Stent Achieves Neointimal Regression at 24 Months

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

OCT STEMI: Imaging-Guided PCI Shows Promise

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

First of Its Kind Study Compares Outcomes of Fractional Flow Reserve-Guided and Angiography-Guided Provisional Side Branch Stenting

COMPARE II: STEMI Patients See Strong Results with Both BES and EES

ABSORB EXTEND: BVS Safe Out to 3 Years

女性在直接PCI后的左心室功能更差的可能原因是就诊延迟

Worse LV Function After Primary PCI in Women May Be Due to Delay in Presentation

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

El Empeoramiento de la Función VI tras una PCI Primaria de las Mujeres podría Deberse a Retrasos a la Hora de Acudir al Hospital

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content